Loading company details...
Latest Form 4 (Dec 22, 2025): David E. Lazar (Chief Executive Officer): Other (see footnotes) of 368,614 shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Dec 22, 2025 | David E. Lazar, Chief Executive Officer | Other (see footnotes) | 368,614 | n/a |
| Nov 26, 2025 | David E. Lazar, Chief Executive Officer | Grant/Award | 900,000 | n/a |
| Oct 25, 2025 | Mark T. Iwicki | Sale | 154,894 | $125.5K |
| Oct 25, 2025 | Mary Reumuth, CHIEF FINANCIAL OFFICER | Sale | 32,230 | $26.8K |
| Oct 25, 2025 | Todd Bazemore | Sale | 47,768 | $39.6K |
| Oct 25, 2025 | Romulus K. Brazzell, Head of Research and Development and Chief Medical Officer | Sale | 46,748 | $38.8K |
| Oct 25, 2025 | Darius Kharabi, CHIEF BUSINESS OFFICER | Sale | 20,806 | $17.3K |
| Oct 2, 2025 | BAKER BROS. ADVISORS LP | Sale | 21,376 | $34.1K |
| Sep 2, 2025 | Todd Bazemore, President and Chief Executive Officer | Grant/Award | 180,000 | n/a |
| Jun 27, 2025 | Darius Kharabi, CHIEF BUSINESS OFFICER | Sale | 4,511 | $18.1K |